Home  >  News
  WuXi STA forms strategic partnership with Beta Pharma,   March 23, 2019
  Novartis to spin-off Alcon eye care business by April 9, 2019,   March 23, 2019
  US FDA approves Sage Therapeutics' Zulresso to treat postpartum depression,   March 22, 2019
  Bayer statement on jury’s decision in phase one of California glyphosate trial,   March 22, 2019
  Alcon Announces Acquisition of PowerVision, Inc.,   March 22, 2019
  C2 PHARMA buys Digoxin API portfolio from Nobilus Ent,   March 20, 2019
  Baxter, bioMérieux collaborate to improve identification and treatment of acute kidney injury,   March 20, 2019
  Roche gets US FDA approval for Tecentriq in combo with chemotherapy to treat adults with extensive-stage SCLC,   March 20, 2019
  AstraZeneca’s saracatinib to treat idiopathic pulmonary fibrosis receives US FDA orphan drug designation,   March 19, 2019
  European Commission approves Praluent to reduce risk of CV events in patients with established cardiovascular disease,   March 19, 2019
  Alcon acquires US-based medical device company, PowerVision,   March 19, 2019
  US FDA approves Allergan's Avycaz to treat pediatric patients with cUTI and cIAI,   March 19, 2019
  US FDA issues new strategies to modernize clinical trials to advance precision medicine, patient protections & efficient products,   March 18, 2019
  BioLife Solutions enters agreement to acquire Astero Bio for US$ 8 million,   March 16, 2019
  Zentiva, Siyiara Enterprises ink agreement to buy Romanian pharma company, Solacium,   March 15, 2019
  Roche receives European approval for Hemlibra to treat people with severe haemophilia A without factor VIII inhibitors,   March 15, 2019
  Metafora Biosystems receives $1.14 mn grant from Bpifrance as part of French government’s Innovation Challenge initiative,   March 14, 2019
  Janssen seeks US FDA approval of Darzalex combination therapy for patients with newly diagnosed multiple myeloma who are transplant ineligible,   March 14, 2019
  Pharmaoffer collaborates with pharmaceutical suppliers to resolve global medicine shortage,   March 13, 2019
  US FDA accepts Allergan's NDA for ubrogepant for acute treatment of migraine,   March 13, 2019

Copyright © 2016 Saffron Media Pvt. Ltd |